FcγRIIa polymorphism in Japanese patients with systemic lupus erythematosus

被引:14
作者
Sato, H [1 ]
Iwano, M [1 ]
Akai, Y [1 ]
Nishino, T [1 ]
Fujimoto, T [1 ]
Shiiki, H [1 ]
Dohi, K [1 ]
机构
[1] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348522, Japan
关键词
Fc gamma receptor IIa polymorphism; systemic lupus erythematosus; anti-double-strand DNA antibody; serum complement; SLE disease activity index (SLEDAI);
D O I
10.1191/096120301677569675
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is an immune complex-mediated disease and organ damage is caused by the deposition of immune complex. Receptors which recognize the Fc portion of immunoglobulin G (FcyR) play a key role in the phagocytosis of immune complexes. As the gene encoding for FcyR of class IIa (FcyRIIa) has two allelic forms, H131 and R131, which differ in their affinity to IgG2, this polymorphism might have implications in handling immune complex. We studied the distribution of the FcyRIIa polymorphism in 90 Japanese patients with SLE. We also examined the association between FcyRIIa polymorphism and the disease activity of SLE and the histopathological findings of lupus nephritis. FcyRIIa polymorphism was determined by PCR and dot blot analysis. The allelic frequency of H131 in patients with SLE was significantly lower (H131/R131 = 0.44/0.56) than that of normal controls (H131/R131 = 0.62/0.38; P < 0.05). No significant association was observed between FcyRIIa polymorphism and the clinical parameters for the activity of SLE. There was no association between FcyRIIa polymorphism and the histological findings in lupus nephritis. The difference in the distribution of FcyRIIa alleles between patients with SLE and normal subjects indicates that this polymorphism is a candidate of susceptibility gene for SLE in Japanese.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 33 条
[1]   PHAGOCYTOSIS MEDIATED BY 3 DISTINCT FC-GAMMA-RECEPTOR CLASSES ON HUMAN-LEUKOCYTES [J].
ANDERSON, CL ;
SHEN, L ;
EICHER, DM ;
WEWERS, MD ;
GILL, JK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04) :1333-1345
[2]  
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[3]  
Barley J, 1996, J HUM HYPERTENS, V10, P31
[4]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[5]   Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease [J].
Bottto, M ;
Theodoridis, E ;
Thompson, EM ;
Beynon, HLC ;
Briggs, D ;
Isenberg, DA ;
Walport, MJ ;
Davies, KA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02) :264-268
[6]  
BRENNER BM, 1996, KIDNEY, P1498
[7]   A SINGLE AMINO-ACID DISTINGUISHES THE HIGH-RESPONDER FROM THE LOW-RESPONDER FORM OF FC RECEPTOR-II ON HUMAN MONOCYTES [J].
CLARK, MR ;
STUART, SG ;
KIMBERLY, RP ;
ORY, PA ;
GOLDSTEIN, IM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (08) :1911-1916
[8]  
DUITS AJ, 1995, ARTHRITIS RHEUM, V39, P1832
[9]  
EMLEN W, 1993, DUBOIS LUPUS ERYTHEM
[10]   DEFECTIVE RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FRANK, MM ;
HAMBURGER, MI ;
LAWLEY, TJ ;
KIMBERLY, RP ;
PLOTZ, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (10) :518-523